引用次数
引用: 45,695
H-指数: 96
I10-指数 : 340
出版物: 1,218
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
Marc Peeters , Timothy Jay Price , Andrés Cervantes , Alberto F. Sobrero
Journal of Clinical Oncology 28 ( 31) 4706 -4713
1,165
2010
Polypharmacy, limited activity, fatigue and insomnia are the most frequent symptoms and impairments in older hematological cancer survivors (70+): Findings from a register-based study on physical and mental health.
Heide Götze , Norbert Köhler , Sabine Taubenheim , Florian Lordick
Journal of Geriatric Oncology 10 ( 1) 55 -59
6
2019
A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond
Carlos Gomez-Martín , Fernando Lopez-Rios , Jorge Aparicio , Jorge Barriuso
Cancer Letters 351 ( 1) 30 -40
49
2014
The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas
Björn LDM Brücher , Karen Becker , Florian Lordick , Ulrich Fink
Cancer 106 ( 10) 2119 -2127
122
2006
The BRIGHTER trial: A phase 3 randomized double-blind study of napabucasin (NAPA) plus paclitaxel (PTX) versus placebo (PBO) plus PTX in patients (pts) with pretreated advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma.
Manish A. Shah , Kohei Shitara , Florian Lordick , Yung-Jue Bang
Journal of Clinical Oncology 36 4010 -4010
11
2018
Two novel registry-based prediction models for overall survival in patients with metastatic esophageal or gastric cancer.
Héctor van den Boorn , Ameen Abu-Hanna , Emil ter Veer , Jessy Joy van Kleef
Journal of Clinical Oncology 36 4021 -4021
1
2018
A retrospective comparative exploratory study on two Methylentetrahydrofolate Reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients
Susanne Blank , Sivaramakrishna Rachakonda , Gisela Keller , Wilko Weichert
BMC Cancer 14 ( 1) 58 -58
13
2014
Imagine a world without cancer
Björn LDM Brücher , Gary Lyman , Richard van Hillegersberg , Raphael E Pollock
BMC Cancer 14 ( 1) 186 -186
14
2014
Final report of assessment of response to neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma patients by 18-FDG-PET
Björn Brücher , Hinrich Wieder , Florian Lordick , Karen Becker
Journal of Clinical Gastroenterology 40
2
2006
The value of a classification of histopathological response by residual tumor cells in patients with neoadjuvant treated esophageal squamous cell carcinomas
Björn Brücher , Hinrich Wieder , Florian Lordick , Karen Becker
Journal of Clinical Gastroenterology 40
2006
Organotypic slice cultures of human gastric and esophagogastric junction cancer.
Justus Koerfer , Sonja Kallendrusch , Felicitas Merz , Christian Wittekind
Cancer Medicine 5 ( 7) 1444 -1453
30
2016
Internet-based perioperative exercise program in patients with Barrett's carcinoma scheduled for esophagectomy [iPEP - study] a prospective randomized-controlled trial.
Daniel Pfirrmann , Suzan Tug , Oana Brosteanu , Matthias Mehdorn
BMC Cancer 17 ( 1) 413
17
2017
Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.
Georg-Martin Haag , Gertraud Stocker , Julia Quidde , Dirk Jaeger
BMC Cancer 17 ( 1) 509 -509
7
2017
TOPGEAR : a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
Trevor Leong , B Mark Smithers , Michael Michael , Val Gebski
BMC Cancer 15 ( 1) 532 -532
167
2015
Efficacy of a brief manualized intervention Managing Cancer and Living Meaningfully (CALM) adapted to German cancer care settings: study protocol for a randomized controlled trial
Katharina Scheffold , Rebecca Philipp , Dorit Engelmann , Frank Schulz-Kindermann
BMC Cancer 15 ( 1) 592 -592
26
2015
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
Jens Hoeppner , Florian Lordick , Thomas Brunner , Torben Glatz
BMC Cancer 16 ( 1) 503 -503
104
2016
Age and gender differences in anxiety and depression in cancer patients compared with the general population.
Andreas Hinz , Philipp Yorck Herzberg , Florian Lordick , Joachim Weis
European Journal of Cancer Care 28 ( 5)
66
2019
Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial
Michael A. Ströhlein , Florian Lordick , Dominik Rüttinger , Klaus-Uwe Grützner
Onkologie 34 ( 3) 101 -108
56
2011
Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
Eva Segelov , Florian Lordick , David Goldstein , Lorraine A. Chantrill
Expert Review of Anticancer Therapy 17 ( 10) 951 -964
1
2017
Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
Amitesh C Roy , Jeremy Shapiro , Matt Burge , Christos S Karapetis
Expert Review of Anticancer Therapy 20 ( 4) 305 -324
2020